Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo

Author：      

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.4, 2014-01, pp. : 1954-1960

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of nonsmall cell lung cancer cells in vitro and in vivo

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1079-1088

Spandidos Publications

Access to resources Recommend Favorite

RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo

By      

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1197-1204

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo

By            

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1271-1276

Spandidos Publications

Access to resources Recommend Favorite

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1943-1947

Spandidos Publications

Access to resources Recommend Favorite

miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo

By        

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 3053-3060

Spandidos Publications

Access to resources Recommend Favorite